# TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment

> **NCT00023439** · — · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 300 (estimated)

## Conditions studied

- Tuberculosis

## Interventions

- **OTHER:** Nucleic Acid Amplification Methods for diagnosis

## Key facts

- **NCT ID:** NCT00023439
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2011-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00023439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00023439, "TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT00023439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*